SK Biopharmaceuticals Co., Ltd. (326030.KS) KSC

128,500.00

+100(+0.08%)

Updated at November 14 03:03PM

Currency In KRW

Valuation

Market Cap8.7T
Enterprise Value8.56T
P/E Ratio39.25
PEG Ratio20.6
Price/Sales Ratio16.19
Price/Book Ratio16.88
Enterprise/Revenue15.95
Enterprise/EBITDA42.99

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.41
Operating Margin0.24

Management Effectiveness

Return On Assets0.27
Return On Equity0.5

Income Statement

Revenue547.6B
Revenue/Share7,914.46
Gross Profit504.5B
EBITDA100.71B
Net Income240.74B
Diluted EPS3,066.97

Balance Sheet

Total Cash222.6B
Total Cash/Share2,840.3
Total Debt74.99B
Total Debt/Equity0.13
Current Ratio2.19
Book Value Per Share7,835.22

Price History

52-Week Change23.15
52-Week High130,500
52-Week Low86,900
Moving Average 50 Days109,130
Moving Average 200 Days103,519.5

Statistics

Average Volume225,133
Shares Outstanding78.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A